Evolus to Participate in Two Upcoming Investor Conferences
March 02, 2021 16:05 ET
|
Evolus
NEWPORT BEACH, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...
Evolus Announces Promotion of Crystal Muilenburg to Chief Marketing Officer
February 26, 2021 09:00 ET
|
Evolus
NEWPORT BEACH, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...
Evolus Announces Preliminary, Unaudited, Fourth Quarter and Full Year 2020 Net Revenue
February 23, 2021 09:00 ET
|
Evolus
NEWPORT BEACH, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS) today announced its preliminary, unaudited, net revenues for the fourth quarter and full year ended December 31,...
Evolus to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
February 19, 2021 16:05 ET
|
Evolus
NEWPORT BEACH, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...
Evolus Provides Update on United States International Trade Commission (ITC) Case
December 16, 2020 17:45 ET
|
Evolus
Section 337 Violation Partially Affirmed by ITC Jeuveau® Sales and Marketing Continue Under Bond All Options Under Review to Resolve Legal Dispute NEWPORT BEACH, Calif., Dec. 16, 2020 (GLOBE...
Evolus Announces Promotion of Michael Mazen Jafar to Chief Commercial Officer and Jeff Plumer to General Counsel
October 29, 2020 16:10 ET
|
Evolus
NEWPORT BEACH, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...
Evolus Reports Third Quarter 2020 Results and Provides Business Update
October 29, 2020 16:05 ET
|
Evolus
Q3 2020 Net Revenue of $17.7 Million; 34 Percent Increase Over Q3 2019 Cash1 Position Increased Over Q2 2020 to $110.1 Million NEWPORT BEACH, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) --...
Evolus to Participate in Three Upcoming Investor Conferences
September 08, 2020 08:30 ET
|
Evolus
NEWPORT BEACH, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...
Evolus Reports Second Quarter 2020 Results and Provides Business Update
August 10, 2020 16:05 ET
|
Evolus
Q2 2020 Net Revenue $7.8 Million, Up from $2.3 Million in Q2 2019 $40 Million Convertible Note Financing Closed in July 2020 Pro Forma June 30, 2020 Cash1 Position of $124.8 Million...
Evolus to Report Second Quarter 2020 Financial Results and Provide a Business Update on Monday, August 10, 2020
July 27, 2020 16:01 ET
|
Evolus
NEWPORT BEACH, Calif., July 27, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...